MHealthSpot, a website/blog devoted to the latest developments in mobile health, reported on the recent MedCityNews story on MR3Health and our proprietary dermal temperature device, TempTouch. The FDA cleared device will be an integral part of MR3’s service to health insurers as the only at-home solution for the detection and prevention of diabetic foot ulcers. Read the MHealthSpot story here.